尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Biniszkiewicz Detlev, 董事. Officer active across 1 company, notably iTeos Therapeutics, Inc.. Cumulatively, 1 filings have been recorded. History available since 3 January 2022. The latest transaction was filed on 3 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Biniszkiewicz Detlev is a Director at iTeos Therapeutics, Inc. In this role, he contributes to the governance of the company and strategic decision-making. His experience in the pharmaceutical sector is an asset for iTeos Therapeutics, Inc.